Search



Engineering Next-Generation Antibody-Drug ConjugatesOctober 31 - November 1, 2016
Engineering Next-Generation Antibody-Drug Conjugates
Lisbon
Use of CRISPR & RNAi for Drug DiscoveryNovember 15-16, 2016
Use of CRISPR & RNAi for Drug Discovery
Lisboa
Optimizing Leads and Predicting Drug ToxicityNovember 15-16, 2016
Optimizing Leads and Predicting Drug Toxicity
Lisboa
Antibody-Drug ConjugatesJanuary 10-11, 2017
Antibody-Drug Conjugates
San Diego, CA
Drug Discovery ChemistryApril 23-27, 2017
Drug Discovery Chemistry
San Deigo, CA
GPCR-Targeted Drug DesignApril 24-25, 2017
GPCR-Targeted Drug Design
San Deigo, CA
Fragment-Based Drug DiscoveryApril 25-26, 2017
Fragment-Based Drug Discovery
San Deigo, CA
Biophysical Approaches for Drug DiscoveryApril 27, 2017
Biophysical Approaches for Drug Discovery
San Deigo, CA
Drug Discovery for Autoimmunity and InflammationMay 1-2, 2017
Drug Discovery for Autoimmunity and Inflammation
Boston, MA
Antibody-Drug Conjugates I: New Targets, Payloads and Alternative FormatsMay 3-4, 2017
Antibody-Drug Conjugates I: New Targets, Payloads and Alternative Formats
Boston, MA
Antibody-Drug Conjugates II: Advancing Toward the ClinicMay 4-5, 2017
Antibody-Drug Conjugates II: Advancing Toward the Clinic
Boston, MA

By Series:
By Region:
CHI Partners

Genetic Engineering News 

BioProcess International